NCT06746909

Brief Summary

SCD and MCI are very heterogeneous conditions, which can be prodromal to different types of dementia. The application of data driven clustering methods on neuroimaging and inflammatory data aims at identifying the features characterizing subgroups of subjects at high risk of developing overt dementia. This approach promises to develop tailored early interventions for subjects with profiles of cognitive decline correlating with high risk of progression. To this end in this project, we propose to examine in these subjects both brain structure and cerebral blood flow (CBF) through MR T1-weighted and pCASL (pseudo-continuous arterial spin labeling) imaging and the neuroinflammatory status. The latter will be done by measuring the populations of innate and adaptive immune cells, the chemokines that are required to attract these cells to their potential sites of action in the CNS, and the cytokines by means they exert their function. The analyses performed in aged subjects with MCI and in SCD, will allow identifying common mechanisms predisposing to an increased susceptibility to progression to overt cognitive decline.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
115

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Feb 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Feb 2022Jun 2026

Study Start

First participant enrolled

February 1, 2022

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

December 18, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 24, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

December 24, 2024

Status Verified

November 1, 2024

Enrollment Period

3.3 years

First QC Date

December 18, 2024

Last Update Submit

December 20, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Short term training effects

    The MCI-training and MCI-no training, the SCD-training and SCD-no training groups will be compared at T7 in terms of cognitive performances, CBF, gray matter atrophy (both CBF and GM atrophy will be evaluated on different regions of interest) and inflammatory markers.

    7 months

Secondary Outcomes (1)

  • Sample stratification

    7, 14 and 28 months

Study Arms (6)

MCI training

ACTIVE COMPARATOR

After baseline assessment the MCI-training group will receive a 7 months-long multidomain training, including cognitive, physical exercise and music therapy; Enrolled subjects will be assigned to mixed-gender classes of maximum 10 subjects each and given 2 sessions of 60 minutes supervised cognitive training per day, 3 times a week, and one of 60 minutes supervised aerobic physical activity per day, 3 times a week for 7 months.

Other: Multidomain cognitive training and physical training

MCI no-training

NO INTERVENTION

Follow up of natural history of subjects after 7 months

healthy subjects

NO INTERVENTION

Follow up of natural history of subjects after 7 months

SCD

NO INTERVENTION

Follow up of natural history of subjects after 28 months

SCD training

ACTIVE COMPARATOR

After baseline assessment the MCI-training group will receive a 7 months-long multidomain training, including cognitive, physical exercise and music therapy; Enrolled subjects will be assigned to mixed-gender classes of maximum 10 subjects each and given 2 sessions of 60 minutes supervised cognitive training per day, 3 times a week, and one of 60 minutes supervised aerobic physical activity per day, 3 times a week for 7 months.

Other: Multidomain cognitive training and physical training

SCD no-training

NO INTERVENTION

Follow up of natural history of subjects after 7 months

Interventions

The cognitive training programme will be based on 8 cycles composed by 18 sessions of exercises and activities aimed at stimulating multiple cognitive functions. Each cycle will last 3 weeks, after which the same kind of cognitive stimulation sessions will be restarted, with exercises and activities of increased complexity. Each cycle will be structured in sessions aimed at stimulating specific cognitive domains and in sessions focused on multimodal activities (music-therapy, cineforum, etc.). The physical training will include aerobic exercise on an ergometer cycle, whose duration will be increased gradually from 10 to 20 minutes followed by exercises targeted to improve muscle strength, physical function, neuromuscular control and flexibility.

MCI trainingSCD training

Eligibility Criteria

Age65 Years - 89 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • age between 65 and 89 years; 5 years of schooling;
  • diagnosis of Mild Cognitive Impairment (Croisile et al., 2011) or
  • diagnosis of Subjective Cognitive Decline (Jessen et al., 2014).

You may not qualify if:

  • neurological pathologies; dementia;
  • psychiatric disorders;
  • pathologies or orthopedic problems limiting participation to the aerobic physical training program and to the MR imaging.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Ospedaliera Universitaria Pisana

Pisa, 56126, Italy

RECRUITING

Central Study Contacts

Paolo Bosco Bosco, PhD

CONTACT

Michela Tosetti, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

December 18, 2024

First Posted

December 24, 2024

Study Start

February 1, 2022

Primary Completion

May 30, 2025

Study Completion (Estimated)

June 30, 2026

Last Updated

December 24, 2024

Record last verified: 2024-11

Locations